SGSven Gläser

Sven Gläser

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sven Gläser has a total of 80 co-authors. Here are the top co-authors by number of shared publications:

  • Ralf Ewert

    Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany

    3 shared publications
  • Beate Koch

    Department of Internal Medicine B - Cardiology, Intensive Care, Pulmonary Medicine and Infectious Diseases, University of Greifswald, Greifswald, Germany

    2 shared publications
  • C. Schäper

    Klinik für Innere Medizin B – Kardiologie, Pneumologie/Infektiologie Intensivmedizin und Weaningzentrum, Universitätsmedizin Greifswald

    2 shared publications
  • Christoph Schäper

    Department of Internal Medicine B - Cardiology, Intensive Care, Pulmonary Medicine and Infectious Diseases, University of Greifswald, Greifswald, Germany

    2 shared publications
  • Felix J. F. Herth

    Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany

    2 shared publications
  • R. Ewert

    Klinik für Innere Medizin B – Kardiologie, Pneumologie/Infektiologie Intensivmedizin und Weaningzentrum, Universitätsmedizin Greifswald

    2 shared publications

Latest Publications

  • Open Access

    Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry

    by Michael Kreuter, Jeff Swigris, David Pittrow, Silke Geier, Jens Klotsche, Antje Prasse, Hubert Wirtz, Dirk Koschel, Stefan Andreas, Martin Claussen, et al.

    The INSIGHTS-IPF registry provides one of the largest data sets of clinical data and self-reported patient related outcomes including health related quality of life (QoL) on patients with idiopathic pulmonary fibrosis (IPF). We aimed to describe associations of various QoL instruments between each other and with patient characteristics at baseline. Six hundred twenty-three IPF patients with available QoL data (St George’s Respiratory Questionnaire SGRQ, UCSD Shortness-of-Breath Questionnaire SoB, EuroQol visual analogue scale and index EQ-5D, Well-being Index WHO-5) were analysed. Mean age was 69.6 ± 8.7 years, 77% were males, mean disease duration 2.0 ± 3.3 years, FVC pred was 67.5 ± 17.8%, DLCO pred 35.6 ± 17%. Mean points were SGRQ total 48.3, UCSD SoB 47.8, EQ-5D VAS 66.8, and WHO-5 13.9. These instruments had a high or very high correlation (exception WHO-5 to EQ-5D VAS with moderate correlation). On bivariate analysis, QoL by SGRQ total was statistically significantly associated with clinical symptoms (NYHA; p < 0.001), number of comorbidities (p < 0.05), hospitalisation rate (p < 0.01) and disease severity (as measured by GAP score, CPI, FVC and 6-min walk test; p < 0.05 each). Multivariate analyses showed a significant association between QoL (by SGRQ total) and IPF duration, FVC, age, NYHA class and indication for long-term oxygen treatment. Overall, IPF patients under real-life conditions have lower QoL compared to those in clinical studies. There is a meaningful relationship between QoL and various patient characteristics. The INSIGHTS-IPF registry is registered at Clinicaltrials.gov ( NCT01695408 ).


  • Open Access

    Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies

    by for the COSYCONET study group, Margarethe E. Wacker, Rudolf A. Jörres, Annika Karch, Armin Koch, Joachim Heinrich, Stefan Karrasch, Holger Schulz, Annette Peters, Sven Gläser, et al.

    Health-related quality of life (HRQL) is an important patient-reported outcome measure used to describe the burden of chronic obstructive pulmonary disease (COPD) which is often accompanied by comorbid conditions. Data from 2275 participants in the COPD cohort COSYCONET and from 4505 lung-healthy control subjects from the population-based KORA and SHIP studies were pooled. Main outcomes were the five dimensions of the generic EQ-5D-3 L questionnaire and two EQ-5D index scores using a tariff based on valuations from the general population and an experience-based tariff. The association of COPD in GOLD grades 1–4 and of several comorbid conditions with the EQ-5D index scores was quantified by multiple linear regression models while adjusting for age, sex, education, body mass index (BMI), and smoking status. For all dimensions of the EQ-5D, the proportion of participants reporting problems was higher in the COPD group than in control subjects. COPD was associated with significant reductions in the EQ-5D index scores (-0.05 points for COPD grades 1/2, -0.09 for COPD grade 3, -0.18 for COPD grade 4 according to the preference-based utility tariff, all p < 0.0001). Adjusted mean index scores were 0.89 in control subjects and 0.85, 0.84, 0.81, and 0.72 in COPD grades 1-4 according to the preference-based utility tariff and 0.76, 0.71, 0.68, 0.64, and 0.58 for control subjects and COPD grades 1-4 for the experience-based tariff respectively. Comorbidities had additive negative effects on the index scores; the effect sizes for comorbidities were comparable to or smaller than the effects of COPD grade 3. No statistically significant interactions between COPD and comorbidities were observed. Score differences between COPD patients and control subjects were most pronounced in younger age groups. Compared with control subjects, the considerable reduction of HRQL in patients with COPD was mainly due to respiratory limitations, but observed comorbidities added linearly to this effect. Younger COPD patients showed a greater loss of HRQL and may therefore be in specific need of comprehensive disease management. NCT01245933


  • Open Access

    Association of circulating irisin and cardiopulmonary exercise capacity in healthy volunteers: results of the Study of Health in Pomerania

    by Nils Kerstholt, Ralf Ewert, Matthias Nauck, Thomas Spielhagen, Tom Bollmann, Beate Stubbe, Stephan B Felix, Henri Wallaschofski, Sven Gläser, Nele Friedrich

    Irisin, a recently discovered myokine, is assumed to be secreted by muscle cells in response to exercise and is involved in the regulation of energy metabolism by browning white adipose tissue cells. However, due to the fact that previous studies revealed conflicting results concerning the association between irisin and exercise, the aim of the present study was to investigate the potential relationship between irisin and exercise capacity in a population-based setting. From the population-based Study of Health in Pomerania (SHIP-TREND) 334 men and 406 women with irisin measurements were selected and a standardised symptom limited cardiopulmonary exercise test was used. Exercise capacity was quantified by oxygen uptake at anaerobic threshold (VO2@AT), peak exercise (peakVO2) and maximum power output at peak exertion. In addition, the oxygen pulse was assessed. ANOVA and multivariable linear regression analyses were performed stratified by sex and adjusted for age, weight, height and smoking. In men, we observed inverse associations between irisin serum concentration and exercise capacity assessed by peakVO2 and maximum power output. In contrast, in women a trend towards a positive relationship between irisin and peakVO2 was detected, whereas none of the other parameters showed significant associations with irisin. Based on a large population sample, our results did not confirm the previous reported positive linkage between exercise and irisin. Thus the relationship needs further investigation in particular with respect to sex differences.


  • Open Access

    Chronic Obstructive Pulmonary Disease and Diabetes Mellitus: A Systematic Review of the Literature

    by Sven Gläser, Stefan Krüger, Martin Merkel, Peter Bramlage, Felix J.F. Herth

    The objective of this systematic review was to discuss our current understanding of the complex relationship between chronic obstructive pulmonary disease (COPD) and type-2 diabetes mellitus (T2DM). We performed a systematic search of the literature related to both COPD and diabetes using PubMed. Relevant data connecting both diseases were compiled and discussed. Recent evidence suggests that diabetes can worsen the progression and prognosis of COPD; this may result from the direct effects of hyperglycemia on lung physiology, inflammation or susceptibility to bacterial infection. Conversely, it has also been suggested that COPD increases the risk of developing T2DM as a consequence of inflammatory processes and/or therapeutic side effects related to the use of high-dose corticosteroids. In conclusion, although there is evidence to support a connection between COPD and diabetes, additional research is needed to better understand these relationships and their possible implications.


  • Open Access

    Serum thyroid-stimulating hormone levels are not associated with exercise capacity and lung function parameters in two population-based studies

    by Till Ittermann, Sven Gläser, Ralf Ewert, Stephan Felix, Henry Völzke, Marcus Dörr

    Thyroid dysfunction has been described to be linked to a variety of cardiovascular morbidities. Through this pathway thyroid function might also be associated with cardiorespiratory function and exercise capacity. So far only few patient-studies with small study populations investigated the association between thyroid dysfunction and exercise capacity. Thus, the aim of our study was to investigate the association of serum thyroid-stimulating hormone (TSH) levels with lung function and cardiopulmonary exercise testing (CPET) in the general population.


  • Open Access

    Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis – The Predictive Value of Exercise Capacity and Gas Exchange Efficiency

    by Sven Gläser, Anne Obst, Beate Koch, Beate Henkel, Anita Grieger, Stephan B. Felix, Michael Halank, Leonhard Bruch, Tom Bollmann, Christian Warnke, et al.

    Exercise capacity and survival of patients with IPF is potentially impaired by pulmonary hypertension. This study aims to investigate diagnostic and prognostic properties of gas exchange during exercise and lung function in IPF patients with or without pulmonary hypertension. In a multicentre setting, patients with IPF underwent right heart catheterization, cardiopulmonary exercise and lung function testing during their initial evaluation. Mortality follow up was evaluated. Seventy-three of 135 patients [82 males; median age of 64 (56; 72 years)] with IPF had pulmonary hypertension as assessed by right heart catheterization [median mean pulmonary arterial pressure 34 (27; 43) mmHg]. The presence of pulmonary hypertension was best predicted by gas exchange efficiency for carbon dioxide (cut off ≥152% predicted; area under the curve 0.94) and peak oxygen uptake (≤56% predicted; 0.83), followed by diffusing capacity. Resting lung volumes did not predict pulmonary hypertension. Survival was best predicted by the presence of pulmonary hypertension, followed by peak oxygen uptake [HR 0.96 (0.93; 0.98)]. Pulmonary hypertension in IPF patients is best predicted by gas exchange efficiency during exercise and peak oxygen uptake. In addition to invasively measured pulmonary arterial pressure, oxygen uptake at peak exercise predicts survival in this patient population.


  • Influence of smoking and obesity on alveolar-arterial gas pressure differences and dead space ventilation at rest and peak exercise in healthy men and women

    by Sven Gläser, Till Ittermann, Beate Koch, Christoph Schäper, Stephan B. Felix, Henry Völzke, Raik Könemann, Ralf Ewert, James E. Hansen


  • Referenzwerte für die Spiroergometrie – Ergebnisse der Study of Health in Pomerania (SHIP)

    by S. Gläser, T. Ittermann, C. Schäper, A. Obst, M. Dörr, T. Spielhagen, S. B. Felix, H. Völzke, T. Bollmann, C. F. Opitz, et al.

    Die Interpretation spiroergometrischer Parameter beruht überwiegend auf dem Vergleich zu Referenzwerten. Der Beschreibung von Normalwertbereichen kommt somit eine hohe methodische Bedeutung zu. Im Rahmen der Study of Health in Pomerania (SHIP) bei 1706 Probanden erhobene spiroergometrische Messwerte wurden zur Erstellung der Referenzwerte herangezogen. Die Probanden wurden einem symptomlimitierten Maximalbelastungstest entsprechend eines modifizierten Jones-Protokolles auf einem Sitzfahrradergometer unterzogen. Sämtliche Studienteilnehmer wurden einem umfangreichen Interview sowie Untersuchungsprogramm unterzogen. Nach Ausschluss von aktiven Rauchern sowie Probanden mit Hinweisen auf kardiopulmonale oder muskulo-skelettale Erkrankungen wurde eine Referenzpopulation von 616 Gesunden (333 Frauen) im Alter von 25 bis 85 Jahren ausgewertet. Mittels quantiler Regression wurden Referenzwertformeln einschließlich oberer und unterer Normwertgrenzen erstellt. Sämtliche Messwerte wurden für zentrale Einflussfaktoren korrigiert. Die Studie stellt Referenzwertgleichungen für zentrale spiroergometrische Messparameter zur Verfügung. The interpretation of gas exchange measured by cardiopulmonary exercise testing (CPET) depends on reliable reference values. Within the population based Study of Health in Pomerania (SHIP) CPET was assessed in 1706 volunteers. The assessment based on symptom limited exercise tests on a bicycle in a sitting position according to a modified Jones protocol. CPET was embedded in an extensive examination program. After the exclusion of active smokers and volunteers with evidence of cardiopulmonary and musculoskeletal disorders the reference population comprised 616 healthy subjects (333 women) aged 25 to 85 years. Reference equations including upper and/or lower limits based on quantile regression were assessed. All values were corrected for the most important influencing factors. This study provides reference equations for gas exchange and exercise capacity assessed within a population in Germany.


  • Gastroösophagealer Reflux bei idiopathischer Lungenfibrose

    by S. Gläser, R. Ewert, C. Schäper